Hosking Partners LLP Increases Holdings in Trupanion, Inc. $TRUP

Hosking Partners LLP lifted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 4.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 430,930 shares of the financial services provider’s stock after purchasing an additional 20,260 shares during the quarter. Hosking Partners LLP owned 1.00% of Trupanion worth $18,651,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Millennium Management LLC grew its stake in Trupanion by 73.5% during the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after acquiring an additional 113,490 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Trupanion by 66.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 161,781 shares of the financial services provider’s stock valued at $8,955,000 after purchasing an additional 64,704 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Trupanion by 7.0% in the second quarter. Geode Capital Management LLC now owns 860,988 shares of the financial services provider’s stock worth $47,662,000 after purchasing an additional 56,671 shares during the period. Invesco Ltd. raised its position in shares of Trupanion by 35.1% in the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after buying an additional 48,781 shares in the last quarter. Finally, Intech Investment Management LLC grew its position in Trupanion by 130.3% during the second quarter. Intech Investment Management LLC now owns 80,736 shares of the financial services provider’s stock worth $4,469,000 after buying an additional 45,680 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Piper Sandler dropped their price target on Trupanion from $67.00 to $60.00 and set an “overweight” rating for the company in a research report on Friday, December 19th. Stifel Nicolaus cut their price target on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, December 29th. Wall Street Zen downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Finally, Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Trupanion presently has a consensus rating of “Moderate Buy” and an average price target of $52.25.

Insider Activity at Trupanion

In other Trupanion news, COO John R. Gallagher sold 6,383 shares of the company’s stock in a transaction on Friday, November 28th. The shares were sold at an average price of $34.82, for a total value of $222,256.06. Following the completion of the transaction, the chief operating officer directly owned 32,721 shares in the company, valued at approximately $1,139,345.22. This represents a 16.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 9,803 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $35.31, for a total transaction of $346,143.93. Following the completion of the sale, the chief executive officer owned 151,899 shares of the company’s stock, valued at $5,363,553.69. This trade represents a 6.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 41,307 shares of company stock worth $1,556,742 in the last 90 days. Company insiders own 5.42% of the company’s stock.

Trupanion Stock Down 2.0%

Shares of NASDAQ:TRUP opened at $35.78 on Thursday. The stock has a market capitalization of $1.55 billion, a P/E ratio of 99.39 and a beta of 1.58. The stock’s 50-day moving average price is $37.41 and its 200-day moving average price is $43.67. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.31. Trupanion, Inc. has a 12-month low of $31.00 and a 12-month high of $57.88.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a return on equity of 4.48% and a net margin of 1.10%.The company had revenue of $366.92 million for the quarter, compared to the consensus estimate of $361.58 million. During the same quarter in the previous year, the business earned $0.03 earnings per share. Trupanion’s revenue was up 12.0% compared to the same quarter last year. On average, equities analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.